TRAF6 and periodontitis: Thus, this study demonstrated that A20 inhibits osteoclastogenesis through inhibition of TRAF6‐dependent autophagy in hPDLCs under hypoxic conditions, which may provide A20 as a new therapeutic target for treating bone loss in periodontitis.